Len Baum, RPh

Len Baum — Principal Leonard (Len) Baum RPh, has over 36 years of leadership experience in global product development and regulatory science covering a broad range of prescription and over-the counter (OTC) therapeutic and diagnostic imaging drugs, nutritionals and biologics. He has hands on and leadership experience in the strategic planning and processing of INDs, NDAs, BLAs and their foreign equivalents, Rx to OTC switch and monographs and in launching new products with competitive labeling and advertising claims. Extensive experience in presentations to Heath Authorities, including Advisory Committees and at industry trade meetings and Expert Ad Boards, and conducting product safety reviews. Len also has broad experience in conducting and managing activities related to mergers & acquisitions, due diligence, and product licensing activities. Proven leadership skills in building, training and leading high performance teams across International sites, including the US, Canada, EU, and Japan. Len has served as VP Regulatory Affairs (RA) for Bayer Healthcare Consumer Care, VP Global RA for Aventis Behring, President and COO Advanced Magnetics, as well as regulatory positions with Bristol Meyers Squibb/Squibb Diagnostics, Hoechst-Roussel and Parke-Davis/Warner Lambert. He has also been active in helping to shape the regulatory environment with a history of appointments and volunteering on industry and professional committees.